High prevalence of insulin resistance among Brazilian chronic hepatitis C patients
AUTOR(ES)
Villar, Livia Melo, Caldas, Gabriela Cardoso, Scalioni, Leticia de Paula, Miguel, Juliana Custódio, Silva, Elisangela Ferreira da, Marques, Vanessa Alves, Villela-Nogueira, Cristiane Alves, Lewis-Ximenez, Lia Laura, Lampe, Elisabeth
FONTE
Arch. Endocrinol. Metab.
DATA DE PUBLICAÇÃO
2017-12
RESUMO
ABSTRACT Objective: This study aims to estimate the prevalence of insulin resistance (IR) among chronic hepatitis C (CHC) patients and their related laboratory and demographic data. Subjects and methods: In this study, non-diabetic CHC patients referred to Viral Hepatitis Ambulatories from Rio de Janeiro (Brazil) donated blood samples. Insulin was measured using a chemiluminescence immunoassay. IR was determined by HOMA-IR, where HOMA-IR > 2 was defined as IR. Results: A total of 214 CHC patients were recruited (123 females aged 53.6 years ± 10.9 years). IR was present in 133 patients (62.1%) and was associated in bivariate analysis to higher mean values of age (p = 0.040), triglycerides (p = 0.032), glucose (p = 0.000), insulin (p = 0.000), waist circumference (p = 0.001), and body mass index (p = 0.007); however, none of these variables were significant in the multivariate analysis. Conclusions: The high prevalence of IR was observed among CHC patients, and there was no difference in clinical or laboratory parameters when both groups were compared in the multivariate analysis. This high IR prevalence could lead to a high risk for development of cardiovascular disease and metabolic disorders.
Documentos Relacionados
- Previous hepatitis E virus infection, cirrhosis and insulin resistance in patients with chronic hepatitis C
- Treatment of chronic hepatitis C virus infection among Brazilian haemophiliacs
- High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension
- Three Cases of Infection with Hepatitis C Virus Genotype 5 among Brazilian Hepatitis Patients
- High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence.